EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Dow Jones Top Company Headlines at 7 PM ET: Anthropic Adds New Board Member as It Eyes IPO | Moderna ... | Morningstar
Dow Jones Top Company Headlines at 5 PM ET: Anthropic Adds New Board Member as It Eyes IPO | Moderna ... | Morningstar
Moderna, Inc. (MRNA) Price Forecast: Breakout Signals New Bull Trend
Stock market today: Dow, S&P 500, Nasdaq gains fizzle to cap week of sharp losses as AI fears grow
Dow Jones Top Company Headlines at 3 PM ET: Anthropic Adds New Board Member as It Eyes IPO | Moderna ... | Morningstar
Traders Buy High Volume of Call Options on Moderna (NASDAQ:MRNA) - Markets Daily
Stock market today: S&P 500, Dow, Nasdaq rise as CPI inflation cools, but weekly losses loom
Stock Traders Purchase High Volume of Moderna Call Options (NASDAQ:MRNA)
Moderna Inc (MRNA) Q4 2025 Earnings Call Highlights: Strategic Cost Reductions Amidst Financial ...
Moderna's mRNA Technology Has Potential Across Vaccines, Oncology, and Rare Diseases | Morningstar
Moderna (NASDAQ:MRNA) Announces Quarterly Earnings Results, Beats Estimates By $0.68 EPS
Dow Jones Top Company Headlines at 1 PM ET: Anthropic Adds New Board Member as It Eyes IPO | Moderna ... | Morningstar
Stock market today: S&P 500, Dow, Nasdaq rise after CPI inflation cools more than expected
Pharma and biotech are back, says UBS' Michael Yee
Moderna beats Q4 revenue estimate - BNN Bloomberg
Earnings live: Moderna stock pops on revenue growth, Rivian surges, Applied Materials jumps
Dow Jones Top Company Headlines at 11 AM ET: Anthropic Adds New Board Member as It Eyes IPO | Moderna ... | Morningstar
Moderna (NASDAQ:MRNA) Trading 7.2% Higher Following Better-Than-Expected Earnings
Moderna Q4 Earnings Call Highlights | MarketBeat
Dow Jones Top Company Headlines at 9 AM ET: Moderna Narrows Loss, Reiterates 10% Revenue Growth Target | Dubai ... | Morningstar
Moderna (MRNA) Stock Slips Despite Beating Q4 Revenue and Earnings Estimates
Moderna Just Crushed Estimates While Everyone Was Looking the Other Way
Why did the U.S. FDA decline to review the new mRNA influenza vaccine? - The Hindu
Moderna beats quarterly revenue estimates on resilient sales of COVID shot
Moderna Q4 Earnings Call Highlights - Stock Observer
FDA Refuses to Review Moderna's New Flu Shot
FDA rejects Moderna's mRNA flu vaccine application - for reasons with no basis in the law - Yahoo News Canada
Dassault Systèmes SE (OTC:DASTY) Q4 2025 Earnings Call Transcript
Biotech Turnaround: How Moderna Went From Revenue Collapse to YTD Rally Leader
US FDA declines Moderna flu vaccine review amid vaccine guidance rollback | Health News | Al Jazeera
FDA defends its decision to not review Moderna's mRNA flu shot
FDA Refuses To Review Moderna's Application For Experimental Flu Shot | ZeroHedge
Barclays Starts Moderna, Inc. (MRNA) Neutral as Biotech Outlook Improves
Stocks making the biggest moves midday: ACHC, VRT, MRNA, U, GNRC
FDA refuses to review Moderna flu shot in surprise setback
Moderna dips on flu vaccine RTF letter | BioWorld
Moderna (MRNA) Stock Falls 9% After FDA Rejects Flu Vaccine Application
FDA Denies Review of Moderna's Influenza Vaccine Application, Shares Plunge 8%, ETPharma
Moderna Drops Premarket as Regulatory Setback Clouds 2026 Revenue Path | Investing.com UK
First mRNA vaccine to be produced in UK approved by regulators - Yahoo News Canada
Moderna shares fall as FDA declines to review new flu vaccine
Moderna, Inc. (NASDAQ:MRNA) Receives Consensus Rating of "Reduce" from Analysts
FDA sends 'refusal-to-file' to Moderna over new flu vaccine
Moderna shares fall after FDA refuses to review influenza vaccine application
Leave it to CBER: Prasad squad socks Moderna with flu RTF | BioWorld
FDA Issues Refusal-to-File Letter For Moderna's Investigational Flu Vaccine MRNA-1010; Stock Down
Moderna Stock Slips After FDA Refuses Flu Vaccine Review | Morningstar
FDA refuses to review Moderna's application for mRNA flu vaccine, company says | CNN
Moderna says FDA refuses to review application for flu shot
Assessing Moderna (MRNA) Valuation As Earnings And Pipeline Updates Draw Investor Focus
FDA refuses to review Moderna's influenza vaccine application
Jim Cramer on Moderna: "One of the Hottest Stocks in the Market This Year"
What Does the Street Think About Moderna, Inc. (MRNA)?
FDA refuses to review Moderna's flu vaccine in latest setback | Health & Fitness | ArcaMax Publishing
FDA refuses to review Moderna's flu vaccine in latest setback | News & Features | ArcaMax Publishing
Jim Cramer's Game Plan: 19 Stocks in Focus
Sensitive detection of cancer antigens enabled by user-defined peptide libraries
1 Stock to Buy, 1 Stock to Sell This Week: Cisco, Moderna | Investing.com UK
1 Stock to Buy, 1 Stock to Sell This Week: Cisco, Moderna | Investing.com
Moderna Balances $5b Patent Trial Risk With Oncology Leadership Shift
Why Moderna (MRNA) Is Down 6.9% After Judge Lets US$5 Billion Patent Lawsuit Proceed
Moderna (MRNA) Valuation Check As Rare Disease Deal And New Development Chief Refocus Growth Plans
TIME100 Talks Health Summit (Full Event)
Moderna (MRNA) to Release Quarterly Earnings on Friday
Ares Announces Record Fourth Quarter and Full-Year 2025 U.S. Direct Lending Origination Activity | Morningstar
Jim Cramer on Moderna: "Even Though the Stock's on the Mend, There Are Many Pharma and Biotech Names That I Like Better" - Insider Monkey
Moderna, Merck report cancer vaccine breakthrough in melanoma trial | Fox Business Video
MIAMI, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Defiance ETFs today
Analysts Offer Insights on Healthcare Companies: Merck KGaA (GB:0O14) and Moderna (MRNA) | Markets Insider
Biotech Stocks To Consider - February 3rd - Markets Daily
Analysts Offer Insights on Healthcare Companies: Moderna (MRNA), Mesoblast Limited (OtherMEOBF) and Wave Life Sciences (WVE) | Markets Insider
AlphaQuest LLC Buys 13,096 Shares of Moderna, Inc. $MRNA - Markets Daily
Moderna said revenue would grow in 2026 for the first time since 2021, says Jim Cramer
Pfizer News | Markets Insider
Merck News | Markets Insider
Moderna Again Fails to Shift Most Covid-Shot Patent Costs to US
Option traders moderately bearish in Moderna with shares down 3.89% | Markets Insider
Moderna reverses lower after court issues memo in patent fight with Arbutus | Markets Insider
Moderna rises after Delaware court issues memo in patent fight with Arbutus | Markets Insider
Moderna, Inc.'s (NASDAQ:MRNA) Price Is Right But Growth Is Lacking After Shares Rocket 43% - Simply Wall St News
Moderna VP and regulatory expert moves to private practice
Moderna Rare Disease Deal And Leadership Shift Raise Valuation Questions
Mitsubishi UFJ Trust & Banking Corp Makes New $2.35 Million Investment in Moderna, Inc. $MRNA - Markets Daily
91,010 Shares in Moderna, Inc. $MRNA Purchased by Mitsubishi UFJ Trust & Banking Corp
Privium Fund Management B.V. Lowers Holdings in Moderna, Inc. $MRNA
Moderna's Chief Medical Officer Jacqueline Miller Resigns as Company Shifts Focus, ETPharma
Biotech Stocks To Follow Today - January 30th - Stock Observer
Moderna CMO Jacqueline Miller to step down
Universal Beteiligungs und Servicegesellschaft mbH Has $2.06 Million Holdings in Moderna, Inc. $MRNA - Daily Political
Moderna Announces Strategic Collaboration with Recordati to Globally Commercialize Investigational Propionic Acidemia Therapeutic (mRNA-3927) | Morningstar
Jim Cramer on Moderna: "We Have to Wait and See"
Moderna Shifts Vaccine Funding Approach And Expands mRNA Oncology Ambitions
Moderna News
Dividend Stocks and Investing: What are the most popular dividend stocks in 2026?
Bitcoin (BTCUSD) is seeing a modest rise: Is BTC about to reverse and head lower?
Alphabet (GOOG) stock is trading down: What’s happening with Alphabet Inc.?
Investment for beginners 2026: Is now a good time to buy Vanguard S&P 500 ETF?
